Navigation Links
Governor Proclaims November 1-7 Health Science and Technology Recognition Week

MADISON, WI -In recognition of the impact of Wisconsins health science industry on the states economy and the health of its citizens, Wisconsin Governor Jim Doyle has declared November 1-7 Health Science and Technology Recognition Week to encourage sponsorship of programs and activities that will promote education of health science and technology in Wisconsin. The proclamation was issued in part i......

Full article >>> osium, Wisconsin Technology Network is publishing a series of Visionary" columns written by Wisconsins technology leaders and government officials that focus on their visions for Wisconsins future technology development and growth.

Wisconsin Technology Network is producing a health technology symposium, The Information Age of Healthcare: From Fail and Fix to Predict that will explore the ......

Full article >>> isconsin Technology Council, "The Governors proclamation shows that Wisconsin is on its way to achieving critical mass in Life Science and Information Technology. The combination of the Wisconsin Life Sciences and Venture Conference in Madison and the Evolving Healthcare Technology Conference at the Medical College of Wisconsin speaks to the states emerging prominence in the field.

"Scien......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 10/16/03


Related biology technology :

1. Surgical products company wins Governors Business Plan Contest
2. MatriLab wins Governors Business Plan Contest
3. Governors third business-plan contest kicks off
4. Tech Digest: President to honor WARF; plus, Governors tech-transfer award for entrepreneurs
5. Governor wants $2 million for biofuels in budget
6. Governors business-plan competition starts another round
7. Governor tells UW to scrap network plans
8. Governor tells state, university to work together on IT
9. Sound Focus plans to enter home-entertainment market after taking Governors prize
10. Governors business-plan contest has a surprise ending
11. 27 finalists advance in Governors Business Plan Contest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... oncology and dermatology biopharmaceutical company, today is providing ... its previously announced rights offering of up to ... stock and Series C Convertible Preferred Stock to ... As previously announced, the rights offering ...
(Date:2/24/2017)... ... 24, 2017 , ... FireflySci, Inc is an explosive small business that continues ... goal of bringing their powerful cuvette and spectrophotometer calibration to the spectroscopy ... is going on as they add yet another mark on the global map. , ...
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 2017  Seattle,s upscale Capitol Hill neighborhood, with its swanky shops, ... a head lice treatment salon to set up shop. But ... and a French bistro on E Madison Ave, and CEO ... any old lice clinic, we pride ourselves on being a ... some of the stigma associated with lice. Everyone can get ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
Breaking Biology News(10 mins):